N.M.A. Idzerda

n.m.a.idzerda umcg.nl


  1. Better prediction of drug response in diabetic kidney disease: a biomarker approach to personalize therapy

    Idzerda, N., 2020, [Groningen]: Rijksuniversiteit Groningen. 140 p.

    Research output: ThesisThesis fully internal (DIV)Academic

  2. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

    CARMELINA Investigators, 15-Jan-2019, In : Circulation. 139, 3, p. 351-361 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Future and Novel Compounds in the Treatment of Diabetic Nephropathy

    Idzerda, N., Pena, M., de Zeeuw, D. & Heerspink, H., 2019, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Roelofs, J. & Vogt, L. (eds.). Springer, p. 515-539 540 p.

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  4. Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers

    Idzerda, N. M. A., Stefansson, B. V., Pena, M. J., Sjostrom, D. C., Wheeler, D. C. & Heerspink, H. J. L., 21-Apr-2019, In : Nephrology, Dialysis, Transplantation. 7 p., gfz064.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (9) »

ID: 20200157